{
    "2018-11-14": [
        [
            {
                "time": "",
                "original_text": "194家企业激烈角逐第三批56个药品集采，医保支出每年有望节省70亿元",
                "features": {
                    "keywords": [
                        "药品集采",
                        "医保支出",
                        "节省",
                        "企业竞争"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "59家药企入选创新能力1000强",
                "features": {
                    "keywords": [
                        "药企",
                        "创新能力",
                        "1000强"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "昭衍新药：创新药研发离不开小白鼠实验，它恰好是这条赛道上的唯一标的",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "创新药",
                        "小白鼠实验",
                        "唯一标的"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞2类新药获批 百亿非甾体抗炎抗风湿药市场将迎新品",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "新药",
                        "非甾体抗炎抗风湿药",
                        "百亿市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：市监局征求《疫苗管理法》意见 荐11股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "市监局",
                        "疫苗管理法",
                        "政策意见"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 市监局征求《疫苗管理法》意见",
                "features": {
                    "keywords": [
                        "医药行业",
                        "市监局",
                        "疫苗管理法",
                        "政策意见"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 临床试验默许制来临, 天津规划星级药店",
                "features": {
                    "keywords": [
                        "医药生物",
                        "临床试验默许制",
                        "天津",
                        "星级药店"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}